Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2006
11/16/2006CA2612145A1 Methods of mapping polymorphisms and polymorphism microarrays
11/16/2006CA2608643A1 Gene-based algorithmic cancer prognosis
11/16/2006CA2608337A1 Use of ammonium and phosphate ions for improving the detection of luciferase
11/16/2006CA2608151A1 Snapback oligonucleotide probe
11/16/2006CA2608142A1 Methods and compositions for assessment of pulmonary function and disorders
11/16/2006CA2608103A1 Screening assays for compounds regulating dj-i expression
11/16/2006CA2608093A1 Novel targets for the identification of antibiotics that are not susceptible to antibiotic resistance
11/16/2006CA2608068A1 Novel steroid 5 .alpha.-reductase
11/16/2006CA2607851A1 Affinity adsorbents for plasminogen
11/16/2006CA2607661A1 A device and method for two-stage nucleic acid amplification
11/16/2006CA2607243A1 Bladder cancer biomarkers and uses thereof
11/16/2006CA2607147A1 Human monoclonal antibodies to programmed death 1(pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
11/16/2006CA2607104A1 Sequence enabled reassembly (seer) - a novel method for visualizing specific dna sequences
11/16/2006CA2606916A1 Liquid crystal based analyte detection
11/16/2006CA2605015A1 Compositions and assays to detect influenza virus a and b nucleic acids
11/15/2006EP1722233A2 Screening method for different indications comprising BNPI and/or DNPI
11/15/2006EP1722225A1 A method for diagnosing immunity recurrent spontaneous abortion and method for treating and monitoring
11/15/2006EP1721993A2 Kits and methods for the detection of target nucleic acids with help of tag nucleic acids
11/15/2006EP1721992A2 Methods and nucleic acids for analyses of cellular proliferative disorders
11/15/2006EP1721991A1 Method of detecting nucleic acid and utilization thereof
11/15/2006EP1721987A1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
11/15/2006EP1721985A1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles
11/15/2006EP1721980A1 Method of producing recombinant sucrose synthase, use thereof in the production of sucrose-determination kits, method of producing adpglucose and method of obtaining transgenic plants having leaves and reserve organs which accumulate a high concentration of adpglucose and starch
11/15/2006EP1721979A1 Compositions and methods for increasing bone mineralisation
11/15/2006EP1721978A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof
11/15/2006EP1721977A2 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
11/15/2006EP1721975A1 Method of detecting and identifying gram-negative obligative anaerobic bacterium
11/15/2006EP1721972A2 Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna
11/15/2006EP1721971A1 Screening method
11/15/2006EP1721970A1 Method of preparing genome library and genome library prepared thereby
11/15/2006EP1721965A1 Method for the preparation and use of protozoan cultures
11/15/2006EP1721609A2 Pyridylpyrimidine derivatives as effective compounds against prion infections and prion diseases
11/15/2006EP1721165A2 New proliferation markers in clinical practice and their use for cancer prognosis or diagnosis
11/15/2006EP1721160A1 Method for covalently immobilising biomolecules on organic surfaces
11/15/2006EP1721159A2 Breast cancer prognostics
11/15/2006EP1721158A2 Modulators of angiogenesis
11/15/2006EP1721149A1 Analyte sensor, and associated system and method employing a catalytic agent
11/15/2006EP1721015A2 Primer and probe design for efficient amplification and detection of hcv 3' non-translating region
11/15/2006EP1721014A2 Method for detecting and quantifying rare mutations/polymorphisms
11/15/2006EP1721013A2 Surrogate markers of neuropathic pain
11/15/2006EP1721012A2 Biologically-active dna-binding sites and related methods
11/15/2006EP1721011A1 Methods, compositions and kits for use in polynucleotide amplification
11/15/2006EP1721010A2 Inhibition of superoxide dismutase by tetrathiomolybdate: identification of new anti-angiogenic and antitumor agents
11/15/2006EP1721009A2 Hybridization method as well as hybridization microarray and hybridization kit
11/15/2006EP1721008A2 Diagnostic and therapeutic use of mal2 gene and protein for neurodegenerative diseases
11/15/2006EP1721007A2 P53 wild-type as biomarker for the treatment with mtor inhibitors in combination with a cytotoxic agent
11/15/2006EP1721006A1 Target genes for inflammatory bowel disease
11/15/2006EP1721005A1 Method for detecting the risk of cancer, coronary heart disease, and stroke by analysing a catalase gene
11/15/2006EP1721004A2 Method for determining the risk of developing a neurological disease
11/15/2006EP1721003A1 Diagnostics and therapeutics for diseases associated with kallikrein 5 (klk5)
11/15/2006EP1721002A2 Method for the identification of sepsis
11/15/2006EP1721001A1 Microarray comprising qc probes and method for fabricating the same
11/15/2006EP1721000A2 Use of rna polymerase as an information-dependent molecular motor
11/15/2006EP1720999A1 Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions
11/15/2006EP1720998A2 Method and apparatus for measuring changes in cell volume
11/15/2006EP1720995A2 Methods and compostions for targeted cleavage and recombination
11/15/2006EP1720990A2 High efficiency peptide production in plant cells
11/15/2006EP1720611A2 Diagnostic marker for cancer
11/15/2006EP1720568A2 Immunostimulatory viral rna oligonucleotides
11/15/2006EP1720539A2 Schizochytrium fatty acid synthase (fas) and products and methods related thereto
11/15/2006EP1613727A4 Approaches to identifying genetic traits in animals
11/15/2006EP1552301A4 Methods of screening cyclic peptides and identifying targets therefor
11/15/2006EP1543157A4 METHODS FOR IDENTIFYING SMALL MOLEDULES THAT MODULATE PREMATURE TRANSLATION TERMINATION AND NONSENSE MEDIATED mRNA DECAY
11/15/2006EP1539996A4 Method of producing plants having enhanced transpiration efficiency and plants produced therefrom
11/15/2006EP1517997A4 Luminogenic protease substrates
11/15/2006EP1504113B1 Method for producing polymer layers
11/15/2006EP1488335A4 Optimization of crossover points for directed evolution
11/15/2006EP1410040B1 Method for identifying substances which modulate interleukin 4 (il-4) signaling
11/15/2006EP1407014B1 Screening method for attenuating or virulence defective microbial cells
11/15/2006EP1406920B1 Novel chromogenic substances and use thereof for the determination of carboxypeptidase activities
11/15/2006EP1387890B1 Peptidylarginine deiminase 6
11/15/2006EP1377828A4 Methods of analysis and labeling of protein-protein interactions
11/15/2006EP1364070B1 Optoelectronic detection system
11/15/2006EP1278584B1 Mipc column cleaning process
11/15/2006EP1092156B1 Method of determining osteoporotic processes
11/15/2006EP1064372B1 Compounds and methods for therapy and diagnosis of lung cancer
11/15/2006EP1047793B1 Biomarkers and targets for diagnosis, prognosis and management of prostate disease
11/15/2006EP1031030A4 Rapid screening assay methods and devices
11/15/2006EP1012294B1 Microbial genes for secreted beta-glucuronidases, gene products and uses thereof
11/15/2006EP0601092B2 Method for the selection of genetically transformed cells and compounds for use in the method
11/15/2006EP0543942B2 Homogeneous assay system
11/15/2006CN1864068A Methods for reducing complexity of a sample using small epitope antibodies
11/15/2006CN1863929A Improved bisulfite conversion of DNA
11/15/2006CN1863928A Diagnostic and therapeutics for osteoporosis
11/15/2006CN1863927A Nucleic acid detection assay
11/15/2006CN1863926A Amplification of signal using a bead-based oligonucleotide assay
11/15/2006CN1863925A Oligonucleotide to be used in determining sporogenous aerobic bacterium and determination method and determination kit for sporogenous aerobic bacerium using the same
11/15/2006CN1863924A Homogeneous multiplex screening assays and kits
11/15/2006CN1863923A Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
11/15/2006CN1863909A Method of extending single-stranded nucleic acid, single-stranded nucleic acid extending apparatus and DNA chip
11/15/2006CN1863815A Polypeptides having brain disposition activity and utilization of the same
11/15/2006CN1861807A Biological articles for detecting hepatitis B virus
11/15/2006CN1861806A Process of detecting K562 monocell expressing p16 gene
11/15/2006CN1861805A Relativity of glycerotriphosphate dehydrogenase gene with primary hypertension
11/15/2006CN1861804A Relativity of epinephrine gene with primary hypertension
11/15/2006CN1861803A Relativity of histamine N-methyl transferase gene with primary hypertension
11/15/2006CN1861802A Multiple PCR reaction kit and detecting process thereof
11/15/2006CN1861783A Inserting tube detecting method of soil and fresh water nematode and plant nematode
11/15/2006CN1860859A Automated system and method for harvesting and multi-stage screening of plant embryos
11/15/2006CN1284972C Substrate activation kit and method of detecting DNA or the like by using the same